Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Optimum platelet inhibition after coronary artery bypass surgery: a prospective, randomised trial comparing platelet aggregation using low- and medium-dose aspirin and clopidogrel
ISRCTN ISRCTN55334531
ClinicalTrials.gov identifier
Public title Optimum platelet inhibition after coronary artery bypass surgery: a prospective, randomised trial comparing platelet aggregation using low- and medium-dose aspirin and clopidogrel
Scientific title
Acronym N/A
Serial number at source N0542115296
Study hypothesis To determine the most effective anti-platelet agent following coronary artery by pass grafting (CABG).
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Coronary artery bypass grafting (CABG)
Participants - inclusion criteria 72 Patients and 36 controls will be recruited from patients proceeding to coronary artery bypass surgery.
Participants - exclusion criteria Does not match inclusion criteria
Anticipated start date 28/08/2002
Anticipated end date 01/06/2004
Status of trial Completed
Patient information material
Target number of participants 108
Interventions Patients will be randomised into treatment allocation to receive either 100 mg aspirin, 325 mg aspirin or identically encapsulated 75 mg clopidogrel daily for 5 days.
Primary outcome measure(s) Platelet aggregation ratio at 5 days.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Cambridge Consortium - Papworth Hospital NHS Trust (UK) - Papworth Hospital Charitable Funds
Trial website
Publications 2004 results in http://www.ncbi.nlm.nih.gov/pubmed/15354104
Contact name Mr  Stephen  Large
  Address Surgical Unit Top Floor
Papworth Hospital NHS Trust
Papworth Everard
  City/town Cambridge
  Zip/Postcode CB3 8RE
  Country United Kingdom
Sponsor Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
  Address The Department of Health
Richmond House
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)207 307 2622
  Fax +44 (0)207 307 2623
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.doh.gov.uk
Date applied 12/09/2003
Last edited 09/09/2009
Date ISRCTN assigned 12/09/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central